ASP Isotopes (NASDAQ:ASPI) Stock Price Up 10.3% - Here's Why

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) traded up 10.3% during mid-day trading on Friday . The company traded as high as $9.04 and last traded at $8.60. 3,363,223 shares were traded during trading, an increase of 34% from the average session volume of 2,514,658 shares. The stock had previously closed at $7.80.

Analyst Ratings Changes

Separately, Canaccord Genuity Group raised their price objective on ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a report on Wednesday.

ASP Isotopes Price Performance

The stock has a 50-day moving average price of $5.48 and a 200 day moving average price of $5.47. The firm has a market cap of $645.46 million, a price-to-earnings ratio of -14.08 and a beta of 3.40. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54.

Insider Buying and Selling at ASP Isotopes

In other news, COO Robert Ainscow sold 66,666 shares of ASP Isotopes stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total value of $383,329.50. Following the transaction, the chief operating officer now directly owns 1,553,326 shares of the company's stock, valued at $8,931,624.50. The trade was a 4.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Paul Elliot Mann sold 316,666 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $1,779,662.92. Following the transaction, the chief executive officer now directly owns 7,315,454 shares in the company, valued at approximately $41,112,851.48. This trade represents a 4.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 766,667 shares of company stock valued at $4,358,502. 21.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On ASP Isotopes

A number of institutional investors have recently made changes to their positions in ASPI. Hanson & Doremus Investment Management acquired a new position in shares of ASP Isotopes in the 4th quarter worth approximately $27,000. BNP Paribas Financial Markets bought a new stake in shares of ASP Isotopes during the 4th quarter worth $34,000. SBI Securities Co. Ltd. grew its holdings in ASP Isotopes by 84.8% in the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after buying an additional 4,299 shares during the last quarter. Avantax Advisory Services Inc. acquired a new position in shares of ASP Isotopes during the fourth quarter valued at about $45,000. Finally, Russell Investments Group Ltd. boosted its stake in ASP Isotopes by 56.3% during the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after buying an additional 3,682 shares in the last quarter. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.